Life Extension ArthroMax™ with Theaflavins & AprèsFlex™, 120 vege caps

Item No: 001617
Availability: In Stock

25% OFF
S$84.70
S$63.53
Ex GST: S$59.37
Pricing for shipping addresses out of Singapore

Qty

Add to Cart

Pre Order Form

We will keep you posted on stock status.

Description
Supplement Facts

As you grow older, age-related stiffness and discomfort in the joints becomes a fact of life. Activities once routine become a challenge as limited mobility hampers your every move.

Inflammatory reactions are regulated by a series of "cytokines" produced in the body. Normal aging results in an unfavorable balance of these cytokines that contributes to persistent inflammatory conditions. Studies have shown that a special fraction found in black tea suppresses proinflammatory cytokines at the genomic level. Scientists have found that these compounds called theaflavins uniquely downregulate the expression of genes associated with inflammatory cytokines.72

ArthroMax® with Theaflavins & AprèsFlex® provides bioactive theaflavin fractions, along with MSM(methylsulfonylmethane), which contains sulfur components that are critically important in maintaining comfortable joint function.73-75 It also contains FruiteX B® OsteoBoron®, a patented form of boron identical to natural plant forms found in food. Considered more bioavailable than other forms of boron, FruiteX B® OsteoBoron® also supports healthy bones and joints.76-78

AprèsFlex® represents a quantum leap forward in the delivery of boswellia to aging joints. Long prized for its ability to help inhibit inflammatory factors, boswellia is especially effective at inhibiting the 5-LOX (5-lipoxygenase) enzyme.

Excess activity of 5-LOX results in the accumulation of leukotriene B4, a pro-inflammatory compound that affects aging joints. Boswellia has been shown to bind directly to the 5-LOX enzyme, preventing it from facilitating production of pro-inflammatory leukotrienes.69,70

AprèsFlex® boswellia absorbs into the blood 52% better than previously available forms of boswellia, for superior effectiveness.71

Supplement Facts

Serving Size 4 vegetarian capsules
Servings Per Container 30
Amount Per Serving
Glucosamine sulfate 2KCI (derived from corn)	2000 mg
Methylsulfonylmethane (MSM)	1000 mg
Black tea theaflavins decaffeinated extract (leaf) [standardized to 12% TF2a fraction (52.8 mg), along with TF-1, TF2b and TF3 theaflavin fractions]	440 mg
AprèsFlex® Indian frankincense (Boswellia serrata) extract (gum resin) [std. to 20% 3-O-acetyl-11-keto-ß-boswellic acid (AKBA) (20 mg)]	100 mg
Boron (calcium fructoborate as patented FruiteX B® OsteoBoron®)	1.5 mg
Other ingredients: vegetable cellulose (capsule), microcrystalline cellulose, vegetable stearate, silica.

AprèsFlex® is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas – Laila Nutra LLC. U.S. Patent No. 8,551,496 and other patents pending.
FruiteX B® and OsteoBoron® are registered trademarks of VDF FutureCeuticals, Inc. U.S. Patent No. 5,962,049.

Dosage and Use

Take four (4) capsules (two capsules in the morning and two capsules in the afternoon) with food, or as recommended by a healthcare practitioner.

Warnings

KEEP OUT OF REACH OF CHILDREN
DO NOT EXCEED RECOMMENDED DOSE
Do not purchase if outer seal is broken or damaged.
When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

References

1. Acta Obstet Gynecol Scand. 1993 Apr;72(3):148-56.
2. Rheum Dis Clin N Am 33 (2007) 149-176
3. Eur J Clin Invest. 1988 Oct;18(5):529-34.
4. Bone. 2001 Mar;28(3):327-31.
5. Endocr Rev. 2011 Feb;32(1):31-63.
6. J Osteoporos. 2011;2011:108324. doi: 10.4061/2011/108324. Epub 2011 Nov 1.
7. J Endocrinol. 2002 Mar;172(3):673-81.
8. Gynecol Obstet Fertil. 2007 Sep;35(9):785-90.
9. J Prosthet Dent. 1995 Jan;73(1):65-72.
10. Am J Clin Nutr. 2000 Sep;72(3):681-9.
11. Clin Calcium. 2006 Oct;16(10):1624-31.
12. J Nutr Elder. 2008;27(1-2):3-27.
13. Calcif Tissue Int. 2011 Feb;88(2):117-29.
14. Clin Ter. 2009;160(2):105-9.
15. Sports Med. 2009;39(6):439-68.
16. J Am Geriatr Soc. 2005 Nov;53(11):1875-80.
17. J Clin Invest. 2006 Dec;116(12):3150-9.
18. Mol Cell Endocrinol. 2011 Dec 5;347(1-2):48-54.
19. Bone Miner. 1994 Dec;27(3):235-47.
20. Biorheology. 2002;39(1-2):237-46.
21. Drugs Aging. 2010 Feb 1;27(2):95-115
22. Magnes Trace Elem. 1990;9(2):61-9.
23. Curr Pharm Des.2003;9(32):2687-704.
24. Ann Nutr Metab. 2002;46(6):249-53.
25. J Int Med Res. 2007 Sep-Oct;35(5):692-5.
26. J Nutr. 1994 Jul;124(7):1060-4.
27. Crit Rev Food Sci Nutr. 2006;46(8):621-8.
28. Magnes Res. 1993 Jun;6(2):155-63.
29. J Reprod Med. 1990 May;35(5):503-7.
30. J Clin Endocrinol Metab. 2010 Jun;95(6):2630-3.
31. Am J Clin Nutr. 1995 Mar;61(3 Suppl):638S-45S.
32. Ann Nutr Metab. 2009;54(3):218-26
33. Toxic Sci. 2006 Jul;92(1):286-94
34. PDR for Nutritional Supplements, 1st ed. Montvale, NJ: Medical Economics Co.; 2001:288-95.
35. J Nutr Sci Vitaminol (Tokyo). 1999 Oct;45(5):509-17.
36. Methods Find Exp Clin Pharmacol. 1995 Sep;17(7):437-42.
37. Scand J Gastroenterol. 2010;45(2):133-8.
38. Osteoporos Int. 2009 Jul;20(7):1175-82.
39. Congest Heart Fail. 2006 Jan-Feb;12(1):9-13.
40. Br J Sports Med. 2006 Sep;40(9): 773-8.
41. Front Biosci. 2004 May 1;9:1278-93.
42. South Med J. 2001 Dec;94(12):1195-201.
43. PDR for Nutritional Supplements, 1st ed. Montvale, NJ: Medical Economics Co.; 2001:60-3.
44. Environ Health Perspect. 1994 Nov;102 Suppl 7:59-63.
45. Bone. 2003 Feb;32(2):127-35.
46. Magnes Res. 1993 Sep;6(3):247-9.
47. Biol Trace Elem Res. 2009 Jun;128(3):239-47.
48. Environ Health Perspect. 1994 Nov;102 Suppl 7:83-5.
49. Crit Rev Food Sci Nutr. 2003;43(2):219-31.
50. Prog Food Nutr Sci. 1993 Oct-Dec;17(4):331-49.
51. Nutr Rev. 2008 Apr;66(4):183-91.
52. J Bone Miner Metab. 2001;19(3):146-9.
53. Osteoporos Int. 2007 Jul;18(7):963-72.,
54. J Bone Miner Res. 2007 Apr;22(4):509-19.
55. Natural Vitamin K2 as Menaquinone-7. Monograph April 2006
56. Blood. 2007 Apr 15;109(8):3279-83.
57. Vitam Horm. 2008;78:393-416.
58. Curr Drug Saf. 2006 Jan;1(1):87-97.
59. Prog Food Nutr Sci. 1992 Oct-Dec;16(4):307-43
60. Valensa. (Data on File.) 2011.
61. Altern Med Rev. 2010 Apr;15(1):84-6.
62. J Am Coll Nutr. 2007 Feb;26(1):39-48.
63. Curr Med Chem. 2009;16(14):1718-45.
64. Curr Rheumatol Rep. 2003 Feb;5(1):7-14.
65. Nutr J. 2008;7:3.
66. Am J Phys Med Rehabil. 2005 Apr;84(4):278-83; quiz 84, 93.
67. World J Gastroenterol. 2007 Feb 14;13(6):945-9.
68. J Nutr Biochem. 2010 May;21(5):381-9.
69. Wien Med Wochenschr. 2002;152(15-16):373-8.
70. J Ethnopharmacol. 2006 Sep 19;107(2):249-53.
71. Mol Cell Biochem. 2011 Aug;354(1-2):189-97.
72. Mol Nutr Foods Res 2006 Feb;50(2):115-22.
73. Adv Ther. 2011 Oct;28(10):894-906.
74. Acta Vet Scand. 2008 Nov 7;50:45.
75. Nutr J. 2008 Oct 27;7:31.
76. Miljkovic D (1999) Boron and carbohydrate complexes and uses thereof. U.S. Patent # 5,962,049.
77. Miljkovic ND, Miljkovic DA, Ercegan GM (2002) Osteoarthritis and Calcium Fructoborate Supplementation: An Open-Label Study. FutureCeuticals Internal Study.
78. Available at: http://www.futureceuticals.com/pdfs/r_d_section/fc_research_page/by_product/fruitex_b/5._fruitexb_increases_bone_density-r_d.pdf Accessed December 17, 2012.
79. Int J Med Sci. 2009;6(6):312-21.
80. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443-6.
81. Int Immunopharmacol. 2011 Jan;11(1):12-8.
82. Int J Clin Pharmacol Res. 2002;22(3-4):101-10.
83. Immunol Rev. 2005;206:232-59.
84. J Vet Pharmacol Ther. 2005 Aug;28(4):385-90.
85. J Vet Pharmacol Ther. 2007 Jun;30(3):275-8.
86. Toxicol Mech Methods. 2007;17(4):189-96.
87. J Anim Physiol Anim Nutr (Berl). Epub 2011 May 30.
88. J Vet Pharmacol Ther. 2009 Dec;32(6):577-84.
89. http://www.koact.net/index.php?id=science Accessed December 17, 2012.
90. BMJ. 2005 Jun 18;330(7505):1400-1.
91. J Clin Endocrinol Metab. 2005 May;90(5):2816-22.
92. Joint Bone Spine. 2004 Jul;71(4):261-3.
93. Int Immunopharmacol. 2009 Mar;9(3):313-8.
94. Clin Rheumatol. 2009 Aug;28(8):931-463.
95. Chandran B, Chakkiath VK, Thomas SPO. A multicentre, randomized, controlled human clinical study to assess the efficacy and safety of Biocurcumax (BCM-95®) compared to diclofenac sodium. Submitted for publication. 2009.
96. Indian J Pharm Sci. 2008 Jul-Aug;70(4):445-9.
97. http://www.docstoc.com/docs/57587485/Nutraceutical-Composition-Comprising-Soluble-Keratin-Or-Derivative-Thereof---Patent-7579317 accessed December 18, 2012.
98. Biol Pharm Bull. 2003 Sep;26(9):1283-8.
99. Life Sci. 2003 Jun 13;73(4):471-85.
100. Mol Pharmacol. 2006 Jun;69(6):1783-90.
101. Mapo Pain Clinic, Seoul. November 2001. Scigenic Co., Ltd. Unpublished study report obtained from manufacturer.
102. J Agric Food Chem. 2008 Nov 26;56(22):10582-93.
103. Nutr J. 2008 Jan 21;7:3.
104. Curr Med Res Opin. 2008 May;24(5):1485-96.
105. Int J Food Sci Nutr. 2009;60 Suppl 2:99-113.
106. Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1365-70.
107. Clin Immunol. 2008 Jul;128(1):66-74. Epub 2008 May 14.
108. Evid Based Complement Alternat Med. 2004 Dec;1(3):251-7.
109. Clin Exp Rheumatol. 2006 Jan-Feb;24(1):25-30.
110. Clin Rheumatol. 2004 Oct;23(5):410-5.
111. Arthritis Res Ther. 2007;9(6):R117.
112. Evid Based Complement Alternat Med. 2007 Jun;4(2):219-24.
113. N Engl J Med. 2006 Feb 23;354(8):795-808.
114. Eksp Klin Farmakol. 2002 Nov-Dec;65(6):67-9.
115. Fortschr Med. 1980 Jun 5;98(21):801-6.
116. Osteoarthritis Cartilage. 2003 Jun;11(6):424-32.
117. Osteoarthritis Cartilage. 1998 Nov;6(6):427-34.
118. Rheumatol Int. 2007 Jan;27(3):213-8.
119. Arthritis Rheum. 2007 Feb;56(2):555-67.

Customer Testimonials

Life Extension ArthroMax™ with Theaflavins & AprèsFlex™, 120 vege caps

S$63.53

Pre Order Form

We will keep you posted on stock status.

Write a review

Related Products

Life Extension Immune Modulator with Tinofend®, 60 vege caps

New Chapter Bone Strength Take Care®, 60 tablets

Life Extension Magnesium Citrate 160mg, 100 vege capsules